Ming‐Min Chang

447 citations
22 papers · 347 indexed · h-index 12
Topics
Fibroblast Growth Factor Research (4 papers)Epigenetics and DNA Methylation (4 papers)Protease and Inhibitor Mechanisms (3 papers)
Partner nations
TaiwanUnited StatesChina

In The Last Decade

Ming‐Min Chang

22 papers receiving 340 citations

Peers

Ming‐Min Chang
Comparison fields: 5 of 77
  • Molecular Biology 191
  • Pharmacology 67
  • Cancer Research 56
  • Plant Science 38
  • Oncology 30
Replace Jixiang Xu with:
Jixiang Xu China
Ji Hye Ha South Korea
Wen-Chang Chang Taiwan
Yuyang Zheng China
Mengfan Liu China
Aodi He China
Hai Jin China
Chen‐Chen Lee Taiwan
Xiao Ni China
Hui Zhen China
Ming‐Min Chang relative to Jixiang Xu China Jixiang Xu's profile →
Citations per field
00.5×3.1×
Jixiang Xu · 1×
Citations per year

Countries citing papers authored by Ming‐Min Chang

Since Specialization
Citations

This map shows the geographic impact of Ming‐Min Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming‐Min Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming‐Min Chang more than expected).

Fields of papers citing papers by Ming‐Min Chang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ming‐Min Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming‐Min Chang. The network helps show where Ming‐Min Chang may publish in the future.

Co-authorship network of co-authors of Ming‐Min Chang

This figure shows the co-authorship network connecting the top 25 collaborators of Ming‐Min Chang. A scholar is included among the top collaborators of Ming‐Min Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ming‐Min Chang. Ming‐Min Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 3
3 34
4 24
5 11
6 3
7 32
8 11
9 11
10 17
11 15
12 12
13 15
14 36
15 35
16 59
17 2
18 6
19 14
20 1

About Ming‐Min Chang

Ming‐Min Chang is a scholar working on Cancer Research, Immunology and Allergy and Developmental Neuroscience, having authored 22 papers that have together received 347 indexed citations. Recurring topics across this work include Fibroblast Growth Factor Research (4 papers), Epigenetics and DNA Methylation (4 papers) and Protease and Inhibitor Mechanisms (3 papers). The work is most often cited by research in Pharmacology (67 citations), Cancer Research (56 citations) and Complementary and alternative medicine (28 citations). Ming‐Min Chang has collaborated with scholars based in Taiwan, United States and China. Frequent co-authors include Bu‐Miin Huang, Chia‐Yih Wang, Shang‐Hsun Yang, Chia‐Ching Wu, Ying-Hui Chen, Bo‐Syong Pan, J.L. Greger, Hung-Chi Cheng, Wen‐Tsan Chang and Bour-Jr Wang. Their work appears in journals such as Scientific Reports, International Journal of Molecular Sciences and Journal of Ethnopharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026